Full-Time

Sr. Director/Vice President

Business Development and Commercial Strategy

Updated on 11/21/2024

Scorpion Therapeutics

Scorpion Therapeutics

51-200 employees

Develops precision oncology treatments for cancer

Biotechnology
Healthcare

Compensation Overview

$260k - $350kAnnually

Senior, Expert

Boston, MA, USA

Category
Business Development
Business & Strategy
Requirements
  • Advanced degree in life sciences, business, or a related field (MBA or PhD preferred).
  • Minimum of 7 years of experience in therapeutics business development, strategic partnerships, or product intelligence within the biotechnology or pharmaceutical industry.
  • Proven track record of successfully leading and closing complex business deals, including licensing agreements and partnerships.
  • Deep understanding of the oncology market, drug development process, and regulatory environment.
  • Strong leadership skills with the ability to influence and collaborate across all levels of the organization.
  • Excellent analytical, negotiation, and communication skills.
  • Ability to thrive in a fast-paced, entrepreneurial environment and drive results under pressure.
Responsibilities
  • Lead the identification, evaluation, and execution of strategic partnerships, licensing opportunities, and acquisitions that align with Scorpion Therapeutics' business goals.
  • Develop and implement business development strategies to expand the company’s product pipeline, enhance market position, and drive revenue growth.
  • Negotiate and close high-value deals with pharmaceutical companies, biotech firms, and research institutions.
  • Provide strategic guidance to senior leadership on business development opportunities and market insights.
  • Oversee the development and execution of product intelligence strategies to support the company’s drug discovery and development efforts.
  • Analyze market trends, competitive landscapes, and emerging technologies to inform product development and strategic decisions.
  • Collaborate closely with R&D, clinical, and commercial teams to ensure alignment between product development and market needs.
  • Establish and maintain relationships with key stakeholders, including industry leaders, potential partners, and investors.
  • Represent Scorpion Therapeutics at industry conferences, networking events, and in negotiations with external partners.
  • Collaborate with the finance team to develop financial models and forecasts for potential partnerships and product opportunities.
  • Contribute to the overall strategic planning process, ensuring that business development initiatives are aligned with corporate goals and financial objectives.
Scorpion Therapeutics

Scorpion Therapeutics

View

Scorpion Therapeutics develops precision oncology treatments aimed at targeting specific cancer drivers. Their approach involves creating drugs that interact with validated cancer targets, enhancing their selectivity and safety to improve treatment outcomes. Unlike many competitors, Scorpion Therapeutics focuses on forming partnerships with larger pharmaceutical companies for the distribution of their drugs, allowing them to concentrate on research and development. Their goal is to provide effective cancer therapies that can be rapidly deployed to healthcare providers and patients worldwide.

Company Stage

Series C

Total Funding

$408.5M

Headquarters

Boston, Massachusetts

Founded

2020

Growth & Insights
Headcount

6 month growth

4%

1 year growth

11%

2 year growth

42%
Simplify Jobs

Simplify's Take

What believers are saying

  • Securing $150M in Series C funding and adding experienced leaders like Adam Friedman and Jeff Albers positions Scorpion for accelerated growth and innovation.
  • The company's world-class team and advisory boards enhance its capability to develop potentially best-in-class cancer treatments, as evidenced by promising preclinical data for STX-478 and STX-721.
  • Partnerships with major pharmaceutical companies provide financial stability and access to global markets, increasing the potential for successful drug commercialization.

What critics are saying

  • Frequent leadership changes, such as the recent CEO and CMO replacements, could lead to strategic instability and affect company morale.
  • The highly competitive oncology market requires continuous innovation to maintain a competitive edge, posing a risk if Scorpion fails to keep pace.

What makes Scorpion Therapeutics unique

  • Scorpion Therapeutics focuses on precision oncology, developing drugs that target specific cancer drivers, unlike broader-spectrum treatments offered by many competitors.
  • Their Precision Oncology 2.0 strategy aims to exceed traditional drug discovery methods in speed, efficiency, and quality, setting them apart in the biotech landscape.
  • Strategic partnerships with established pharmaceutical companies like Pierre Fabre allow Scorpion to leverage extensive distribution networks while focusing on R&D.

Help us improve and share your feedback! Did you find this helpful?